GET THE APP

Special Issue: Pharmaceutical drugs and medicine for COVID-19

Special Issue: Pharmaceutical Drugs and Medicine for COVID-19

An outbreak of the novel coronavirus (COVID -19) rapidly spreading around the world in 2020. COVID-19 is a global outbreak of pneumonia and acute respiratory distress syndrome. The extremely rapid spread of the disease is affecting all age groups, which is leading to an urgent need for prophylactic and curative treatments. Consequently, combatting the causal agent SARS-CoV-2 has emerged as a tremendous challenge. This special issue aims to gathering efforts from academia, pharmaceutical companies, hospitals, international organizations, as well as governments and philanthropic associations to improve our understanding of the disease by using several approaches.

Submission Process

  • Special issue articles can include both original unpublished research articles and review articles related to the specific theme.
  • Manuscripts will be accepted for publishing in the special issue only after getting approved by the peer review committee.
  • All the articles in special issues should strictly adhere to journal style and formatting.
  • All accepted manuscripts can be submitted online via https://www.scholarscentral.org/submission/der-pharmacia-lettre.html or through an email id to editor.dpl@journalsres.com Submission should be accompanied by a cover letter with reference to the concerned special issue theme.

For further information on special issue guidelines and submission process, please contact editor.dpl@journalsres.com

Please visit Instruction for author’s page to know more about article formatting and guidelines: https://www.scholarsresearchlibrary.com/journals/der-pharmacia-lettre/open-access-policy/